Site and mechanism of morphine tolerance in the gastrointestinal tract

Neurogastroenterology and Motility

Volumn 26, Issue 10, 2014, Pages 1361-1367

  Akbarali, H I ^a   Inkisar, A ^a   Dewey, W L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Beta arrestin; Constipation; Opioid; Tolerance

Indexed keywords

BETA ARRESTIN; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; RETINA S ANTIGEN;

CHEMICALLY INDUCED; CONSTIPATION; DRUG EFFECTS; DRUG TOLERANCE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE INNERVATION; METABOLISM; NERVE CELL; PAIN;

ANALGESICS, OPIOID; ARRESTINS; CONSTIPATION; DRUG TOLERANCE; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HUMANS; MORPHINE; NEURONS; PAIN; RECEPTORS, OPIOID, MU;

EID: 84908155207     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12443     Document Type: Review

References (55)

1. Centers for Disease C, Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011; 60: 1487-92.
2. Holzer P. New approaches to the treatment of opioid-induced constipation. Eur Rev Med Pharmacol Sci 2008; 12(Suppl. 1): 119-27.
3. Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 2011; 106: 835-42; quiz 843.
4. Paton WD, Zar MA. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 1968; 194: 13-33.
5. Paton WD. The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol Chemother 1957; 12: 119-27.
6. Nishi S, North RA. Intracellular recording from the myenteric plexus of the guinea-pig ileum. J Physiol 1973; 231: 471-91.
7. North RA. Effects of morphine on myenteric plexus neurones. Neuropharmacology 1976; 15: 719-21.
8. North RA. Opiates, opioid peptides and single neurones. Life Sci 1979; 24: 1527-45.
9. North RA, Williams JT. Extracellular recording from the guinea-pig myenteric plexus and the action of morphine. Eur J Pharmacol 1977; 45: 23-33.
10. North RA, Williams JT. On the potassium conductance increased by opioids in rat locus coeruleus neurones. J Physiol 1985; 364: 265-80.
11. Smith TH, Grider JR, Dewey WL, Akbarali HI. Morphine decreases enteric neuron excitability via inhibition of sodium channels. PLoS ONE 2012; 7: e45251.
12. Roy S, Liu HC, Loh HH. mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res Mol Brain Res 1998; 56: 281-3.
13. Pasternak GW. Molecular insights into mu opioid pharmacology: from the clinic to the bench. Clin J Pain 2010; 26(Suppl. 10): S3-9.
14. Ono H, Nakamura A, Matsumoto K, Horie S, Sakaguchi G, Kanemasa T. Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation. Neurogastroenterol Motil 2014; 26: 1396-407.
15. Ling GS, Paul D, Simantov R, Pasternak GW. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci 1989; 45: 1627-36.
16. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994; 9: 372-82.
17. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76.
18. Yuan CS, Foss JF, O'Connor M, Moss J, Roizen MF. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol 1998; 38: 931-5.
19. Kreek MJ. Medical safety and side effects of methadone in tolerant individuals. JAMA 1973; 223: 665-8.
20. Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-30, e496.
21. Ross GR, Gabra BH, Dewey WL, Akbarali HI. Morphine tolerance in the mouse ileum and colon. J Pharmacol Exp Ther 2008; 327: 561-72.
22. Rezvani A, Huidobro-Toro JP, Hu J, Way EL. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J Pharmacol Exp Ther 1983; 225: 251-5.
23. Leedham JA, Kong JQ, Taylor DA, Johnson SM, Fleming WW. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine. J Pharmacol Exp Ther 1992; 263: 15-9.
24. Collier HO, Cuthbert NJ, Francis DL. Model of opiate dependence in the guinea-pig isolated ileum. Br J Pharmacol 1981; 73: 921-32.
25. Goldstein A, Schulz R. Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br J Pharmacol 1973; 48: 655-66.
26. Grider JR, Makhlouf GM. Suppression of inhibitory neural input to colonic circular muscle by opioid peptides. J Pharmacol Exp Ther 1987; 243: 205-10.
27. Iwata H, Tsuchiya S, Nakamura T, Yano S. Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. Eur J Pharmacol 2007; 21(574): 66-70.
28. Plant OH, Miller GH. Effects of Morphine and some other opium alkaloids on the muscular activity of the alimentary canal 1.Action on the small intestine in unanesthetized dogs and man. J Pharmacol Exp Ther 1926; 27: 361-83.
29. Williams CL, Bihm CC, Rosenfeld GC, Burks TF. Morphine tolerance and dependence in the rat intestine in vivo. J Pharmacol Exp Ther 1997; 280: 656-63.
30. Tan-No K, Niijima F, Nakagawasai O, Sato T, Satoh S, Tadano T. Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice. Eur J Pharm Sci 2003; 20: 357-63.
31. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 2013; 65: 223-54.
32. Bailey CP, Smith FL, Kelly E, Dewey WL, Henderson G. How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? Trends Pharmacol Sci 2006; 27: 558-65.
33. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science (New York, NY) 1999; 286: 2495-8.
34. Raehal KM, Walker JK, Bohn LM. Morphine side effects in beta-arrestin 2 knockout mice. J Pharmacol Exp Ther 2005; 314: 1195-201.
35. Raehal KM, Schmid CL, Groer CE, Bohn LM. Functional selectivity at the {micro}-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol Rev 2011; 63: 1001-19.
36. Kang M, Maguma HT, Smith TH, Ross GR, Dewey WL, Akbarali HI. The role of beta-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract. J Pharmacol Exp Ther 2012; 340: 567-76.
37. Maguma HT, Dewey WL, Akbarali HI. Differences in the characteristics of tolerance to mu-opioid receptor agonists in the colon from wild type and beta-arrestin2 knockout mice. Eur J Pharmacol 2012; 685: 133-40.
38. Maguma HT, De Datta D, Bhave S, Dewey WL, Akbarali HI. Specific localization of beta-arrestin2 in myenteric plexus of mouse gastrointestinal tract. PLoS ONE 2014; 9: e103894.
39. Ling GS, Spiegel K, Lockhart SH, Pasternak GW. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J Pharmacol Exp Ther 1985; 232: 149-55.
40. Pasternak GW, Childers SR, Snyder SH. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 1980; 208: 514-6.
41. Pasternak GW, Snyder SH. Identification of novel high affinity opiate receptor binding in rat brain. Nature 1975; 253: 563-5.
42. Wolozin BL, Pasternak GW. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A 1981; 78: 6181-5.
43. Poonyachoti S, Portoghese PS, Brown DR. Characterization of opioid receptors modulating neurogenic contractions of circular muscle from porcine ileum and evidence that delta- and kappa-opioid receptors are coexpressed in myenteric neurons. J Pharmacol Exp Ther 2001; 297: 69-77.
44. Heyman JS, Williams CL, Burks TF, Mosberg HI, Porreca F. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J Pharmacol Exp Ther 1988; 245: 238-43.
45. Mori T, Shibasaki Y, Matsumoto K, Shibasaki M, Hasegawa M, Wang E, Masukawa D, Yoshizawa K et al. Mechanisms that underlie mu-opioid receptor agonist-induced constipation: differential involvement of mu-opioid receptor sites and responsible regions. J Pharmacol Exp Ther 2013; 347: 91-9.
46. Xu J, Xu M, Rossi GC, Pasternak GW, Pan YX. Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1. Mol Pain 2011; 7: 9.
47. Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 2005; 133: 209-20.
48. Oldfield S, Braksator E, Rodriguez-Martin I, Bailey CP, Donaldson LF, Henderson G, Kelly E. C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics. J Neurochem 2008; 104: 937-45.
49. Thompson RC, Mansour A, Akil H, Watson SJ. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 1993; 11: 903-13.
50. Bream-Rouwenhorst HR, Cantrell MA. Alvimopan for postoperative ileus. Am J Health Syst Pharm 2009; 66: 1267-77.
51. Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther 2014; 40: 771-9.
52. Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 2014; 370: 2387-96.
53. Raehal KM, Bohn LM. beta-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia. Handb Exp Pharmacol 2014; 219: 427-43.
54. DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen XT, Pitis PM et al. A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 2013; 344: 708-17.
55. Soergel DG, Subach RA, Sadler B, Connell J, Marion AS, Cowan CL, Violin JD, Lark MW. First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers. J Clin Pharmacol 2014; 54: 351-7.